DR-TB | Drupal

Fiche Résumée par le SAMU

No resources currently available.

Guides

No resources currently available.

Ressources pour la mise en oeuvre
- MSF TB Patient Education and Counselling Flipchart: DS-TB, MDR-TB & XDR-TB Messages
  
  En savior plus
  
  TB Patient Education and Counselling Flipchart: DS-TB, MDR-TB & XDR-TB Messages
  
  MSFCH DSTB.DRTB_.XDRTB - Flipchart oct2016.pdf
- Counselling toolkit for DRTB (Khayelitsha)
  
  En savior plus
  
  Counselling toolkit for DRTB (Khayelitsha)
  
  Patient support DRTB_Khayelitsha_FINAL.pdf
- WHO: Policy Implementation package for new TB drug introduction (2014)
  
  En savior plus
  
  WHO: Policy Implementation package for new TB drug introduction
  
  WHO_policy_Implementation_package_new_DRTB_Drugs.pdf

Ressources formation
A 12 module TB and DRTB E-Learning course, covering both clinical and programmatic aspects of TB and DRTB is available free, on and off line. It takes approximately 10 hours to complete and is available in English and French. For further details, click here and to register please email samu.elearning@joburg.msf.org.

SAMU hosts an annual one week face-to-face training for DRTB in Cape Town. For full details, click here.

endTB offers a 6-module E-Learning Training to provide guidance to physicians caring for MDR-TB patients enrolled in the endTB project on the use of new and re-purposed drugs. To access the endTB E-Learning, click here.
No resources currently available.

En savoir plus
For further information on DRTB go to the following websites

http://www.msf-tb-symposium.org/2017en/

https://www.msfaccess.org/our-work/tuberculosis

http://www.stoptb.org/

http://www.who.int/tb/en/

https://www.theunion.org/
- Out of Step: TB policies in 29 countries (2017)
  
  En savior plus
  
  Out of Step: TB policies in 29 countries
  
  TB_Report_OutOfStep_3rdEd_ENG_2017.pdf
- Self-administered therapy for DRTB treatment: Experience from MSF Khayelitsha, South Africa
  
  En savior plus
  
  Self-administered therapy for DRTB treatment: Experience from MSF Khayelitsha, South Africa
  
  MSF_SAT_DRTB_Khayelitsha.pdf
- Decentralisation of DRTB treatment: Experience from MSF in Swaziland
  
  En savior plus
  
  Decentralisation of DRTB treatment: Experience from MSF in Swaziland
  
  Decentralisation of DRTB care-2013_OCG_Swazilan.pdf
- endTB Interim Analysis: July 2018
  
  En savior plus
  
  endTB Interim Analysis
  
  endTB interim analysis (13 July 2018).pdf
- MSF DRTB abstracts from the UNION conference 2017
  
  En savior plus
  
  Delamanid for rifampicin resistant tuberculosis an observational cohort study from Khayelitsha
  
  1. Delamanid for rifampicin resistant tuberculosis an observational cohort study from Khayelitsha.pdf
  
  Adverse events over 6 months with delamanid in a programmatic setting in Khayelitsha
  
  2. Adverse events over 6 months with delamanid in a programmatic setting in Khayelitsha.pdf
  
  Accelerating access to delamanid for rifampicin-resistant tuberculosis in Khayelitsha, South Africa
  
  3. Accelerating access to delamanid for rifampicin-resistant tuberculosis in Khayelitsha, South Africa.pdf
  
  Early safety and efficacy of Bedaquiline and Delamanid combination for drug-resistant TB in Armenia, India and South Africa
  
  4. Combination BDQ and DLM late breaker Union2017.pdf

Ressources Additionnelles

No resources currently available.

Corrections

No resources currently available.

Mise à jour

No resources currently available.